AU Stock MarketDetailed Quotes
BIT Biotron Ltd
- 0.039
- +0.001+2.63%
20min DelayNot Open Jul 1 16:00 AET
35.19MMarket Cap-9750P/E (Static)
0.041High0.038Low1.67MVolume0.039Open0.038Pre Close65.44KTurnover0.12552wk High0.23%Turnover Ratio902.28MShares0.02752wk Low-0.005EPS TTM28.54MFloat Cap0.578Historical HighLossP/E (Static)731.83MShs Float0.014Historical Low-0.004EPS LYR7.90%Amplitude--Dividend TTM19.50P/B1Lot Size--Div YieldTTM
About Biotron Ltd Company
Biotron Ltd is a biotechnology company. It is engaged in the funding and management of intermediate and applied biotechnology research and development projects. Its antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. Geographically, it operates only in Australia through biotechnology segment.
Company Profile
SymbolBIT
Company NameBiotron Ltd
Founded1999
MarketASX
Employees4
Fiscal Year Ends06-30
Address56 Delhi Road Suite 3.3
CitySydney
CountryAustralia
Zip Code2113
Phone+61 298050488
Websitehttps://www.biotron.com.au
Share RegistryCOMPUTERSHARE INVESTOR SERVICES PTY LIMITED
6 Hope Street, ERMINGTON, NSW, AUSTRALIA, 2115
02 8234 5000
Company Executives
- Name
- Position
- Salary
- Michael J Hoy
- Non-Executive Director,Non-Executive Chairman
- --
- Susan Margaret Pond
- Non-Executive Director
- --
- Stephen Alister Locarnini
- Non-Executive Director
- --
- Robert Bain Thomas
- Non-Executive Director
- --
- Michelle Miller
- Managing Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
%Chg